EPISODE · Jun 27, 2023 · 48 MIN
Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software
from Vital Signs with Jacob Effron and Nikhil Krishnan · host Thomas Swalla, Jacob Effron, Nikhil Krishnan
Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. 0:00 intro 0:36 getting into healthcare 5:20 what R&D looks like today 8:03 what does Dotmatics do? 13:06 differences in software requirements across biotechs 20:15 bundling vs. “best-of-breed” 23:46 do life sciences need their own data tools? 26:44 incorporating AI into Dotmatics tools 34:38 AI replacing scientists 37:39 how Dotmatics tools can serve companies outside of life sciences 39:50 acquisition strategy 44:43 spaces for innovation in R&D
Embed this episode
What this episode covers
Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences.
Ready to play
Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.